Summary & Overview
HCPCS G8798: Specimen Site Other Than Anatomic Location of Prostate
HCPCS Level II code G8798 denotes a specimen collected from a site other than the anatomic location of the prostate. Nationally, this code matters for accurate procedural documentation, clinical interpretation of prostate-related testing, and downstream billing clarity when specimens originate from alternate anatomic sites. Proper use supports consistent claims adjudication and clinical records when prostate evaluation involves nonprostate samples.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national overview of the code’s clinical purpose, how payers commonly address coverage and billing for nonprostate specimen reporting, and the operational implications for service lines that handle prostate-related diagnostic workflows. The publication provides benchmarks and policy context where available, highlights common billing modifiers and documentation considerations, and summarizes typical sites of service and service types tied to G8798.
This summary is designed for clinicians, billing professionals, and policy analysts seeking a clear national-level reference for HCPCS Level II code G8798. Data not available in the input are explicitly noted within detailed sections.
Billing Code Overview
HCPCS Level II code G8798 describes a specimen site other than anatomic location of prostate. This code is used to indicate that a collected specimen originated from a site distinct from the prostate anatomic location, reflecting a nonprostate sampling site related to procedures or diagnostic workflows involving prostate evaluation.
-
Service type: Diagnostic specimen collection associated with prostate-related evaluation from a nonprostate anatomical site
-
Typical site of service: Outpatient clinic, ambulatory surgery center, hospital outpatient department, or laboratory setting where prostate-related specimens from alternate sites are collected
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old male with a known history of prostate adenocarcinoma who undergoes diagnostic or surveillance procedures where a tissue specimen is obtained from a location other than the anatomic prostate (for example, a pelvic lymph node biopsy, seminal vesicle sampling, or a soft-tissue metastasis). The care episode begins with evaluation by a urologist or oncologist for rising prostate-specific antigen (PSA) or radiologic evidence of a suspicious non-prostatic lesion. The clinician documents indication, imaging guidance used (ultrasound or CT), and informed consent. In the procedure suite or interventional radiology department, sedation or local anesthesia is provided; the lesion is targeted under image guidance; a core needle or excisional sample is obtained and sent to pathology labeled with the specific non-prostatic site. Post-procedure monitoring includes vital signs, management of bleeding or pain, and discharge instructions. Billing uses HCPCS Level II code G8798 to indicate the specimen site was other than the anatomic prostate when reporting specimen source for pathology or cancer registry abstraction. Common payor interactions include preauthorization for biopsy procedures and accurate documentation of specimen site for claim adjudication and cancer reporting to Medicare, Blue Cross Blue Shield, Aetna, Cigna Health, UnitedHealthcare, and BUCA plans.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |